EyePoint, Inc.·4

Mar 24, 4:05 PM ET

Duker Jay S. 4

4 · EyePoint, Inc. · Filed Mar 24, 2026

Research Summary

AI-generated summary of this filing

Updated

EyePoint (EYPT) CEO Jay Duker Sells Shares to Family Trust

What Happened

  • Jay S. Duker, President, CEO and Director of EyePoint, transferred shares and stock options to the Duker Family 2024 Irrevocable Trust on March 23, 2026. The filing reports transfers of 76,766 common shares at $13.11 each (value reported $1,006,402) and transfers of option positions valued at $459,375 (52,500 @ $8.75) and $933,075 (97,500 @ $9.57). In exchange he received a promissory note with a principal amount of $2,398,220.93, the stated fair market value of the securities transferred. The filing treats these as related‑party transfers (transaction code J) rather than open‑market sales, and the reporting person disclaims beneficial ownership of the securities held in the trust.

Key Details

  • Transaction date: March 23, 2026; Form 4 filed March 24, 2026 (timely).
  • Items transferred and reported values:
    • 76,766 shares @ $13.11 = $1,006,402
    • 52,500 options (strike/series noted at $8.75) valued at $459,375 (derivative)
    • 97,500 options (strike/series noted at $9.57) valued at $933,075 (derivative)
    • Total promissory note: $2,398,220.93 (per footnote)
  • Footnotes:
    • Fair market value for shares used the average of the high and low trading price on the date; options valued via Black‑Scholes.
    • Securities in the Family Trust are for the benefit of the reporting person’s children; spouse is trustee; reporting person disclaims beneficial ownership.
    • Portions of the options sold to the trust were fully vested at sale; remaining retained options continue vesting monthly through Jan 5, 2028.
  • Shares owned after the transaction are not specified in the provided excerpt of the filing.

Context

  • This is a related‑party transfer (family trust) and appears to be estate/financial planning rather than a market sale—such transfers do not necessarily indicate the insider’s view on company prospects. The filing discloses derivative (option) transfers and vesting details; no cashless exercise or open‑market sale was reported.

Insider Transaction Report

Form 4
Period: 2026-03-23
Duker Jay S.
DirectorPresident and CEO
Transactions
  • Other

    Common Stock

    [F1]
    2026-03-23$13.11/sh76,766$1,006,402986 total
  • Other

    Common Stock

    [F1][F2]
    2026-03-23$13.11/sh+76,766$1,006,402177,431 total(indirect: By Trust)
  • Other

    Stock Option (Right to Buy)

    [F1][F3]
    2026-03-23$8.75/sh52,500$459,3757,800 total
    Exercise: $13.13Exp: 2031-02-09Common Stock (52,500 underlying)
  • Other

    Stock Option (Right to Buy)

    [F1][F3][F2]
    2026-03-23$8.75/sh+52,500$459,37552,500 total(indirect: By Trust)
    Exercise: $13.13Exp: 2031-02-09Common Stock (52,500 underlying)
  • Other

    Stock Option (Right to Buy)

    [F1][F4]
    2026-03-23$9.57/sh97,500$933,07582,500 total
    Exercise: $20.40Exp: 2034-01-04Common Stock (97,500 underlying)
  • Other

    Stock Option (Right to Buy)

    [F1][F4][F2]
    2026-03-23$9.57/sh+97,500$933,07597,500 total(indirect: By Trust)
    Exercise: $20.40Exp: 2034-01-04Common Stock (97,500 underlying)
Footnotes (4)
  • [F1]On March 23, 2026, the reporting person sold owned shares of ("Shares") and options to purchase ("Options") Common Stock of EyePoint, Inc. (the "Company") to the Duker Family 2024 Irrevocable Trust, (the "Family Trust"), in exchange for a promissory note in the principal amount of $2,398,220.93, representing the fair market value of the Shares and Options. For Shares, the fair market value was determined by utilizing the average of the high and low per share trading price on the date of the sale. For Options, the fair market value was determined using a Black Scholes model. The securities held in the Family Trust are for the benefit of the reporting person's children. The reporting person's spouse is a trustee of the Family Trust. The reporting person disclaims beneficial ownership of the security and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
  • [F2]These securities are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
  • [F3]At the time of the sale, the portion of the options sold to the Family Trust and the remaining portion of the option retained by the reporting person was vested in full.
  • [F4]The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months. At the time of the sale, the portion of the option that was sold to the Family Trust vested in full. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until January 5, 2028.
Signature
/s/ Ron Honig, Attorney-in-Fact|2026-03-24

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT